LPAR6 is the most recently determined G-protein-coupled receptor of the lysophosphatidic
acid receptor, and very few of studies have demonstrated the performance of LPAR6 in …

OBJECTIVE: This study aims to explore the diagnostic and prognostic values of
Lysophosphatidic acid receptor 5 (LPAR5) in non-small-cell lung cancer (NSCLC) and its …

Abstract Background and Objective Lysophosphatidic acid (LPA) has widely been reported
to participate in the numerous biological behaviors of tumors through its receptors. LPA …

Purpose Lysophosphatidic acid (LPA) is a bioactive molecule which participates in many
physical and pathological processes. Although LPA receptor 6 (LPAR6), the last identified …

Prostate cancer is a common malignancy in men worldwide. Lysophosphatidic acid receptor
1 (LPAR1) is a critical gene and it mediates diverse biologic functions in tumor. However, the …

Hepatocellular carcinoma (HCC) is the most commonly diagnosed liver malignancy, ranking
third in the overall global cancer-related mortality. A complex network of interacting proteins …

Purpose Lysophosphatidic acid (LPA) exerts various physiological and pathological effects
by activating its distinct G-protein-coupled LPA receptors. We demonstrated that LPA can …

Abstract Background Lysophosphatidic acids (LPAs) belong to a class of bioactive
lysophospholipids with multiple functions including immunomodulatory roles in tumor …

Background Lysophosphatidic acid receptor 3 (LPAR3) is coupled to G α i/o and G α 11/q
signaling. Previously, we reported that LPAR3 is highly methylated in carcinogen-induced …

Methods The expression of LPAR6 and its clinical characteristics were evaluated on various
databases. The association between LPAR6 and immune infiltrates of various types of …